Perseon Announces Financial Results for First Quarter

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Perseon Announces Financial Results for First Quarter Fiscal Year 2015

SALT LAKE CITY, May 14, 2015 (GLOBE NEWSWIRE) -- Perseon Corporation (Nasdaq: PRSN ) (Perseon or the Company), a leading provider of medical systems that utilize energy to treat cancer, today announced year-to-date operational highlights and financial results for the first quarter ended March 31, 2015 1 .

First Quarter Highlights and Commentary

  • Executing 3-year strategic plan including the successful divestiture of the Company's hyperthermia assets
  • U.S MicroThermX ® sales increased by 43% year-over-year
  • Conducting six ongoing clinical studies
  • Reiterates product pipeline of a next generation generator and new antennae offerings over the next 18-24 months
  • Received two FDA clearances with expanded indications for laparoscopic ablation procedures using image guidance and ablation of non-resectable liver tumors
  • Completed launch of new Perseon corporate name and brand, including launching a new ticker symbol, restructuring management and changing the Board of Directors

"I am pleased with the progress we are making against our strategic initiatives. The team is executing well with a disciplined focus on our energy ablation platform," said Clint Carnell, CEO of Perseon. "I am optimistic about our ability to achieve the goals we outlined this past January."

Financial Results 2

Total revenues were $1,156,626 for the first quarter ended March 31, 2015, compared to total revenues of $1,535,534 for the three months ended March 31, 2014.   The decrease in revenue is directly attributable to a decrease in hyperthermia sales. Revenues recognized from hyperthermia sales have historically fluctuated significantly.  

Total gross margin was $359,888, or approximately 31% of total revenues, for the three months ended March 31, 2015, compared to $676,976, or approximately 44%, for the three months ended March 31, 2014.The decrease in gross margin and gross margin percentage resulted primarily from higher than expected costs to produce the final hyperthermia systems completed and sold in the three months ended March 31, 2015. Gross margin for MicroThermX ® was approximately 58% of revenues for the quarter ended March 31, 2015 compared to 56% for the quarter ended March 31, 2014.

Research and development expenses decreased to $496,635 for the first quarter of fiscal year 2015, from $521,264 for the comparable period last year. Selling, general and administrative expenses for the first quarter of fiscal year 2015 increased to $2,721,864 from $1,715,281 for the comparable period last year.  The increase resulted primarily from nonrecurring corporate restructuring costs and expenses related to the sale of the hyperthermia assets, rebranding efforts, changing the Company's fiscal year-end and resultant reporting requirements, and increased legal costs. As Perseon continues to roll out the MicroThermX product line and the support of its global distribution network, selling, general and administrative expenses may continue to increase over the level reported for the first quarter of fiscal year 2015.

The Company reported a net loss of $2.9 million, or $0.07 per share, for the first quarter of fiscal year 2015, compared to a net loss of $1.6 million, or $0.05 per share, for the comparable period last year.  

As of March 31, 2015, Perseon had cash and cash equivalents of $3.6 million, total current assets of $5.9 million and no long-term debt.

Conference Call and Webcast

Perseon management will host a conference call with a live webcast today at 2:00 p.m. Eastern Time/12:00 p.m. Mountain Time to discuss the financial results for the first quarter ended March 31, 2015.

Individuals interested in listening to the conference call may do so by visiting the Investor Relations section of the Company's website at  www.perseonmedical.com  or by dialing 800.860.2442 from the United States, or 412.858.4600 from outside the United States, and referencing "Perseon Corporation." If you would like to submit a question via email in advance of the conference call, please email tross@finprofiles.com

A telephone replay will be available through May 21, 2015, by dialing 877.344.7529 from the United States, or 412.317.0088 from outside the United States, and entering conference ID 10064204. A webcast replay will be available for 90 days.

About Perseon

Perseon Corporation invests its resources in fighting humanity's worst disease: cancer. Perseon's people are dedicated to finding innovative technologies and means to deliver energy solutions to healthcare providers and patients around the world. MicroThermX® treats soft tissue tumors with precision-focused energy, expanding the options and broadening the opportunities for cancer treatment.

Forward-Looking Statements

Statements contained in this press release that are not historical facts, including statements relating to our focus on microwave ablation to create stockholder value and pursuit of our strategic plans are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. All forward-looking statements are subject to risks and uncertainties, including the risk that for a variety of reasons we may not be able to execute on our strategic plans, and other risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update such statements to reflect events or circumstances arising after such date, except as required by law. 

1 In January 2015, the Board of Directors of Perseon changed the Company's fiscal year end from August 31 to December 31, beginning December 31, 2014. The report covering the Company's transition period ended December 31, 2014 was filed on Form 10-K on March 31, 2015. 

2 Financial results for the three months ended March 31, 2015 include results associated with Perseon's former hyperthermia cancer treatment product offering. Subsequent to the end of the quarter on April 1, 2015, Perseon sold the assets associated with its hyperthermia cancer treatment systems among other assets, certain contracts, inventory, intellectual property and permits, pursuant to an Asset Purchase Agreement with Pyrexar Medical, Inc., a Nevada corporation. A Current Report on 8-K related to the Asset Purchase Agreement was filed with the Securities and Exchange Commission on April 1, 2015.  

PERSEON CORPORATION
(Formerly BSD Medical Corporation)
Condensed Balance Sheets
(Unaudited)
ASSETS March 31, 2015 December 31, 2014
Current assets:    
Cash and cash equivalents $ 3,560,193 $ 5,594,578
Accounts receivable, net of allowance for doubtful accounts of $66,480 and $140,000, respectively 794,575 275,072
Related party trade accounts receivable 2,269 13,471
Inventories, net 1,268,254 1,775,648
Other current assets 259,799 86,583
Total current assets 5,885,090 7,745,352
     
Property and equipment, net 1,204,734 1,140,871
     
  $ 7,089,824 $ 8,886,223
     
LIABILITIES AND STOCKHOLDERS' EQUITY    
     
Current liabilities:    
Accounts payable $ 1,015,861 $ 598,466
Accrued liabilities 856,512 1,105,152
Notes payable, net of discount 846,790 --
Customer deposits 19,825 41,667
Deferred revenue -- 54,218
Total current liabilities 2,738,988 1,799,503
     
Commitments and contingencies    
     
Stockholders' equity:    
Preferred stock, $.001 par value; 10,000,000 shares authorized, no shares issued and outstanding  --  --
Common stock, $.001 par value, 80,000,000 shares authorized, 39,713,540 shares issued 39,714 39,714
Additional paid-in capital 63,723,103 63,587,400
Treasury stock, 24,331 shares at cost (234) (234)
Accumulated deficit (59,411,747) (56,540,160)
Total stockholders' equity 4,350,836 7,086,720
     
  $ 7,089,824 $ 8,886,223
 
PERSEON CORPORATION
(Formerly BSD Medical Corporation)
Condensed Statements of Comprehensive Loss
(Unaudited)
   
  Three Months Ended March 31,
  2015 2014
Revenues:    
Sales $ 1,064,094 $ 1,443,142
Sales to related parties 11,232 12,492
Equipment rental 81,300 79,900
     
Total revenues 1,156,626 1,535,534
     
Cost of revenues:    
Cost of sales 788,105 847,647
Cost of related party sales 6,668 7,964
Cost of equipment rental 1,965 2,947
     
Total cost of revenues 796,738 858,558
     
Gross margin 359,888 676,976
     
Operating costs and expenses:    
Research and development 496,635 521,264
Selling, general and administrative 2,721,864 1,715,281
     
Total operating costs and expenses 3,218,499 2,236,545
     
Loss from operations (2,858,611) (1,559,569)
     
Other income (expense):    
Interest income (expense), net (3,856) 4,874
Other expense, net (9,120) (2,699)
     
Total other income (expense) (12,976) 2,175
     
Loss before income taxes (2,871,587) (1,557,394)
     
Income tax benefit -- --
     
Net loss and comprehensive loss $ (2,871,587) $ (1,557,394)
     
Net loss per common share:    
Basic $ (0.07) $ (0.05)
Diluted $ (0.07) $ (0.05)
     
Weighted average number of shares outstanding:    
Basic 39,689,000 33,982,000
Diluted 39,689,000 33,982,000
 
PERSEON CORPORATION
(Formerly BSD Medical Corporation)
Condensed Statements of Cash Flows
(Unaudited)
   
  Three Months Ended March 31,
  2015 2014
Cash flows from operating activities:    
Net loss $ (2,871,587) $ (1,557,394)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 29,577 31,599
Stock-based compensation 135,703 206,513
(Gain) loss on disposition of property and equipment 2,590 (67)
Amortization of debt discount 2,209 --
Decrease (increase) in:    
Receivables (508,301) 145,941
Inventories 507,394 231,142
Other current assets (173,216) (50,547)
Increase (decrease) in:    
Accounts payable 417,395 (135,539)
Accrued liabilities (248,640) 126,143
Customer deposits (21,842) (91,897)
Deferred revenue (54,218) (38,571)
     
Net cash used in operating activities (2,782,936) (1,132,677)
     
Cash flows from investing activities:    
Proceeds from disposition of property and equipment -- 2,025
Purchase of property and equipment (96,030) (22,657)
     
Net cash used in investing activities (96,030) (20,632)
     
Cash flows from financing activities:    
Proceeds from notes payable, net 844,581 82,465
     
Net cash provided by financing activities 844,581 82,465
     
Net decrease in cash and cash equivalents (2,034,385) (1,070,844)
Cash and cash equivalents, beginning of period 5,594,578 7,423,091
     
Cash and cash equivalents, end of period $ 3,560,193 $ 6,352,247

Tricia Ross Financial Profiles 310-622-8226

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Norris Lake's New Kayak Fleet Propels Tourism Efforts

Updated Category News Views 157

Norris Lake Doubles Down on Water Adventures The winds of change are paddling through Norris Dam State Park as they've launched a new fleet of shiny kayaks, hoping to lure more adventure seekers into the heart of Tennessee. These ain't just boats; they're part of a bigger play by local tourism honchos hungry to pump some adrenaline—and dollars—back into the area. A...

Continue Reading
AdMaven's Mave AI: Revolutionizing Campaign Management

Updated Category News Views 161

Taking the Tedious Out of Advertising You've got to love it when technology actually makes life easier, rather than more complicated. AdMaven's latest fancy toy, the AI assistant Mave, is promising just that. It's designed to take the heavy lifting off advertisers' shoulders, especially the day-to-day grind of tweaking ad settings and monitoring performance. If you've...

Continue Reading
LA Hospitals Shine in Pulmonary Excellence Nationwide

Updated Category News Views 135

Los Angeles Community Hospitals' Recent Recognition You ever stroll into a hospital and wonder if you’re really getting the best care? Well, the folks over at Los Angeles Community Hospitals, covering LA, Norwalk, and Bellflower, just got a big nod from Healthgrades—yeah, the site everyone's checking to find decent healthcare options. They’ve landed among the top...

Continue Reading
Ross Pools Joins Forces with Florida Panthers in 2026

Updated Category News Views 69

An Unlikely Team-Up: Pools and Hockey Well, here's one for the books: a South Florida pool company hitching its wagon to an NHL team. Ross Pools, the folks who’ve been carving out backyard oases in the sizzling Florida sun for over two decades, are now officially aligned with the Florida Panthers. Yeah, the same Panthers that snatched the Stanley Cup not once but twice...

Continue Reading
Quantum X and Everest Cloud Partner in South Asia Push

Updated Category News Views 87

An Unlikely Alliance for Cutting-Edge Tech You gotta admit, the fusion of a U.S.-based tech outfit with a Nepalese cloud provider wasn't the market move anyone saw coming. But here we are—Quantum X is hitching its quantum computing dreams to Everest Cloud's solid local foothold across six South Asian markets. We're talking Nepal, India, Bangladesh, Bhutan, Sri Lanka,...

Continue Reading
Portillo's Faces Legal Heat: Investor Class Action Filed

Updated Category News Views 183

What’s Eating Portillo's? Ah, once upon a misstep in the land of promising expansion, now we have Portillo's Inc. (NASDAQ: PTLO) neck-deep in legal hot water. Those golden fries and famous sandwiches somehow didn't pave the way for stockholder bliss. Why the turmoil? On an ordinary November morning, the DJS Law Group made it clear: They're rallying the troops for a...

Continue Reading
Scientific Games Joins NCPG’s 2026 Campaign Again

Updated Category News Views 242

Scientific Games Backs Responsible Gaming Again It's another year, and here's Scientific Games once more, guns blazing for a cause that's needed more than a few times over—responsible gambling. Those folks got their hearts in the right place, joining the National Council on Problem Gambling's 2026 Gift Responsibly campaign. Ninth time running, no less! It's like...

Continue Reading
Loyalty Programs Cut $1500 Annually for Consumers

Updated Category News Views 132

Loyalty Programs: An Essential Tool for Households In a world where every dollar counts, retail loyalty programs have become more than just a marketing strategy—they're lifelines for American households scraping through each month. According to fresh research by the Retail Industry Leaders Association (RILA) and conducted by market research leader Circana, these...

Continue Reading
Gwen Stefani Kicks Off OCVIBE's New Concert Hall

Updated Category News Views 217

A Homecoming Steeped in Nostalgia Orange County’s about to do a serious throwback, folks! Gwen Stefani is set to headline the opening concert at OCVIBE's spanking new concert hall in Anaheim on March 17, 2027. Curious choice for their opener? Hardly. This gal's practically woven into the county’s tapestry—her roots run deep here, enough to make even the casual music...

Continue Reading
Crocs to Present at Key Industry Conferences

Updated Category News Views 148

Crocs Set to Step into the Spotlight Alright, if there's one thing about Crocs, Inc. (NASDAQ: CROX) that never fails to surprise, it's how they constantly keep everyone on their toes. The iconic casual footwear brand with its whimsical, love-it-or-hate-it reputation is strapping in for not one but two hefty conferences. They've circled November 19 and December 1, 2026, on...

Continue Reading

Top 5 Most Recently Viewed Articles

Compugen's Q4 2025 Results: Is CGEN Set for a Rebound?

Updated Category News Views 168

Compugen Ltd. (NASDAQ: CGEN) is gearing up for its fourth quarter and full-year 2025 financial results set to drop on March 2, 2026, before U. S. markets open. You know how it goes—traders are already sizing up this number drop, trying to parse out if there’s any upside left or if it's just another 'waiting for Godot' situation. Compugen has been riding the waves of...

Continue Reading
Procyon Partners Appoints Rich Franchella to Propel Growth Strategy

Updated Category News Views 384

Procyon Partners' Strategic Growth Through Leadership Appointment Procyon Partners is excited to announce a significant addition to its leadership team with the appointment of Rich Franchella as the Senior Vice President of Business Development. This newly established role is aimed at catalyzing the firm’s growth trajectory and is set to bolster its efforts in...

Continue Reading
SMC Entertainment Expands Horizons With Bateau Acquisition

Updated Category News Views 162

SMC Entertainment Enhances Its Market Position SMC Entertainment, Inc. has taken a significant step in broadening its reach within the financial services sector by acquiring Bateau Asset Management. This strategic move paves the path for SMC to tap into the Australian and Southeast Asian markets, expanding its footprint in the dynamic world of fintech. An Overview of...

Continue Reading
Dustin Moskovitz Expands Asana Holdings with Major Purchase

Updated Category News Views 503

Dustin Moskovitz Expands His Investment in Asana Facebook co-founder Dustin A. Moskovitz, who currently holds the position of Director at Asana, Inc., has recently made headlines by increasing his stake in the company through the acquisition of 225,000 shares. This move highlights his ongoing commitment to the growth and success of Asana. Details of the Share Purchase The...

Continue Reading
GDMining's Innovative Cloud Mining Service Redefines Accessibility

Updated Category News Views 146

GDMining Expands Global Reach with Free Cloud Mining Service The cryptocurrency market is constantly evolving, and GDMining is leading the charge. This innovative platform offers an exciting opportunity for individuals around the globe to earn income from home through its unique cloud mining services. What sets this initiative apart is that it requires no initial...

Continue Reading